Vaccine Quality Articles & Analysis
9 news found
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive portfolio of ELISA Based Assays for vaccine development and bioprocess applications. Vaccine development involves a variety of assays to support vaccine research and development, from early ...
By prioritizing optimization, Alfa Chemistry ensures that their mRNA vaccine solutions remain at the forefront of the industry, consistently delivering vaccines that redefine the boundaries of vaccine technology. mRNA Vaccine Quality Control Equally crucial to the success of mRNA vaccine ...
"End-to-End Support for Your Pharmaceutical Journey", with the commitment to researchers, BOC Sciences will attend the renowned World Vaccine Congress Europe in Barcelona, Spain, from 16 to 19 Octobe World Vaccine Congress Europe has become the world's largest and most established meeting dedicated to vaccines. It brings together the ...
With an expanded portfolio and increasing technical, regulatory, and market challenges for COVID-19 vaccine development, we have decided not to proceed with an IND submission for IBIO-202, our multi-variant COVID-19 vaccine candidate. ...
Its FastPharming® Manufacturing System combines vertical farming, automated hydroponics, and novel glycosylation technologies to rapidly deliver high-quality monoclonal antibodies, vaccines, bioinks and other proteins. iBio is developing proprietary biopharmaceuticals for the treatment of cancers, as well as fibrotic, infectious and autoimmune diseases. ...
There is a special list of mRNA vaccine related raw materials at BOC Sciences, suggesting its enormous contribution to the anti-COVID-19 campaign. ...
As vaccines are given to large numbers of healthy individuals there is a strong focus upon quality, safety and efficacy in assessing their benefit-risk to public health. “This GHC registration accentuates AJ Vaccines’ ambitions to further improve access to high-quality, innovative vaccines to serve ...
Currently, due to the severe situation of the COVID-19 pandemic, the global need for vaccines is still huge. Under this circumstance, BOC Sciences has strengthened its supply capacity of pseudoUridine and derivatives to ease the pressure on the global supply of vaccine raw materials. ...
The site will expand the company's clinical and commercial capabilities for cGMP plasmid DNA used as a critical raw material to develop and manufacture cell and gene-based therapies including life-saving cancer treatments as well as mRNA vaccines. In addition, the site will have the capability to produce large-scale plasmid DNA as a primary drug substance for DNA therapies. ...